FR2901807B1 - Nouveau traitement d'une infection par le vhc - Google Patents

Nouveau traitement d'une infection par le vhc

Info

Publication number
FR2901807B1
FR2901807B1 FR0604806A FR0604806A FR2901807B1 FR 2901807 B1 FR2901807 B1 FR 2901807B1 FR 0604806 A FR0604806 A FR 0604806A FR 0604806 A FR0604806 A FR 0604806A FR 2901807 B1 FR2901807 B1 FR 2901807B1
Authority
FR
France
Prior art keywords
hcv infection
new treatment
treatment
new
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0604806A
Other languages
English (en)
Other versions
FR2901807A1 (fr
Inventor
Michel Ventura
Gin Therese Astier
Simon Litvak
Estelle Dumas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Victor Segalen Bordeaux 2 filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0604806A priority Critical patent/FR2901807B1/fr
Priority to US12/302,678 priority patent/US20110015255A1/en
Priority to EP07765973A priority patent/EP2021482A1/fr
Priority to PCT/FR2007/000899 priority patent/WO2007138193A1/fr
Priority to JP2009512639A priority patent/JP5301433B2/ja
Priority to CA002653910A priority patent/CA2653910A1/fr
Publication of FR2901807A1 publication Critical patent/FR2901807A1/fr
Application granted granted Critical
Publication of FR2901807B1 publication Critical patent/FR2901807B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24241—Use of virus, viral particle or viral elements as a vector
    • C12N2770/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
FR0604806A 2006-05-30 2006-05-30 Nouveau traitement d'une infection par le vhc Expired - Fee Related FR2901807B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0604806A FR2901807B1 (fr) 2006-05-30 2006-05-30 Nouveau traitement d'une infection par le vhc
US12/302,678 US20110015255A1 (en) 2006-05-30 2007-05-30 Treatment of an infection by an rna virus due to an rna dependent rna polymerase
EP07765973A EP2021482A1 (fr) 2006-05-30 2007-05-30 Traitement d'une infection par un virus à arn à une arn polymérase arn dépendante
PCT/FR2007/000899 WO2007138193A1 (fr) 2006-05-30 2007-05-30 Traitement d'une infection par un virus a arn a une arn polymerase arn dependante
JP2009512639A JP5301433B2 (ja) 2006-05-30 2007-05-30 Ｒｎａウイルス及びｒｎａ−依存型ｒｎａポリメラーゼによる感染治療
CA002653910A CA2653910A1 (fr) 2006-05-30 2007-05-30 Traitement d'une infection par un virus a arn a une arn polymerase arn dependante

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604806A FR2901807B1 (fr) 2006-05-30 2006-05-30 Nouveau traitement d'une infection par le vhc

Publications (2)

Publication Number Publication Date
FR2901807A1 FR2901807A1 (fr) 2007-12-07
FR2901807B1 true FR2901807B1 (fr) 2013-08-23

Family

ID=37726550

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0604806A Expired - Fee Related FR2901807B1 (fr) 2006-05-30 2006-05-30 Nouveau traitement d'une infection par le vhc

Country Status (6)

Country Link
US (1) US20110015255A1 (fr)
EP (1) EP2021482A1 (fr)
JP (1) JP5301433B2 (fr)
CA (1) CA2653910A1 (fr)
FR (1) FR2901807B1 (fr)
WO (1) WO2007138193A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9775894B2 (en) * 2013-07-09 2017-10-03 University Of Washington Through Its Center For Commercialization Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19915178A1 (de) * 1999-04-03 2000-10-05 Univ Mainz Johannes Gutenberg Hepatitis C Virus Zellkultursystem
WO2001083736A2 (fr) * 2000-04-21 2001-11-08 Boehringer Ingelheim (Canada) Ltd. Sites d'initiation de novo interne de la polymerase hcv ns5b et leurs applications
AU2001282417A1 (en) * 2000-07-24 2002-02-05 Institute Of Molecular & Cell Biology Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
MXPA03006634A (es) * 2001-01-31 2003-10-15 Bristol Myers Squibb Pharma Co Sistema in vitro para replicacion de virus de acido ribonucleico polimerasa dependiente del acido ribonucleico.
JP2007530049A (ja) * 2004-03-24 2007-11-01 アキリオン ファーマシューティカルズ，インコーポレーテッド 無細胞系における新規に合成されたｒｎａの検出およびｒｎａ合成阻害剤の同定のための定量的アッセイ

Also Published As

Publication number Publication date
FR2901807A1 (fr) 2007-12-07
EP2021482A1 (fr) 2009-02-11
WO2007138193A1 (fr) 2007-12-06
JP2009538610A (ja) 2009-11-12
JP5301433B2 (ja) 2013-09-25
CA2653910A1 (fr) 2007-12-06
US20110015255A1 (en) 2011-01-20
WO2007138193A8 (fr) 2009-07-16

Similar Documents

Publication Publication Date Title
MA28394B1 (fr) Derives d'heteroaryle pour traitement des virus
MA29098B1 (fr) Compositions pour le traitement du vhc
LTPA2016033I1 (lt) Fabri ligos gydymo priemonės
SI1951272T1 (sl) Uporaba lactobacillus za zdravljenje virusnih infekcij
ATE494288T1 (de) Makrozyklische hemmer des hepatitis-c-virus
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
CR9878A (es) Tratamiento y profilaxis de microangiopatias
EP2120566A4 (fr) Composés et compositions pharmaceutiques destinés au traitement d'infections virales
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
IL190478A0 (en) Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
FR2876047B1 (fr) Traitement de polluants par phytolixiviation
EP1965827A4 (fr) Traitement d'etats lies a la demyelination
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
DK1962869T3 (da) Behandling af luftvejssygdomme
DK1981506T6 (da) Langtidsbehandling af hiv-infektion med tcm278
FR2908771B1 (fr) Chitine-glucane d'extrait fongique de granulometrie fine
MA29097B1 (fr) Composes pour le traitement des infections virales par flaviviridae
EA200601889A1 (ru) Лечение инфекционных заболеваний
GB0513096D0 (en) Treatment of microbial infections
DK1709075T3 (da) Behandling af virusinfektioner
DK2056858T3 (da) Behandling af lungesygdomstilstande
DK2054050T3 (da) Behandling af brusksygdomme med FGF-18
ATE525355T1 (de) 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1
MA28694B1 (fr) Traitement des infections bacteriennes
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160129